Scientists Successfully Clone Biotech IPO

Ben Holmes has the market covered: Sundays: This Week in IPOs Tuesdays: This Week's Secondaries Wednesdays: Upcoming Lockup Expirations Fridays: The Quiet Period

Biotech deals are everywhere this week! This is a surprise to me given the total lack of interest in the group last week. The exception of course being Luminex (LMNX Quote) which rocked on its first day out of the box. The difference seems to be that Luminex is a biotech tool builder vs. being a tool user. Drug discovery companies fit into this latter group. The market apparently makes a distinction. Oh well.

That having been said, the real story this week is wireless. This is a screamin' group and you would do well to pay attention.

The IPO market has without question taken a turn towards cold. What do you do? Buy those sectors that are still working -- I call them The Gold Standards and they are: ...